Atrial Fibrillation Market By Type (Surgical, Non-Surgical), By Technology (Radiofrequency, Laser, Cryotherapy, Others), By End User (Hospitals, Specialty Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030
The atrial fibrillation market size was valued at $1,825.8 million in 2020, and is projected to reach $3,370.7 million by 2030, registering a CAGR of 6.4% from 2021 to 2030. Atrioventricular fibrillation (AFib) is a disorder, in which the heart's upper chambers (atria) beat quickly and erratically (fibrillate). Blood can accumulate and clot in the left atrial appendage of the heart as a result of AFib. A stroke can occur when a blood-clot escapes from the left atrial appendage (LAA) and transfers to another parts or organs of the body. Atrial fibrillation can increase the risk of heart stroke, induce chest discomfort, or even trigger a heart attack, especially if the heart beat is extremely rapid, and can produce blood clots in the heart that spread to other organs.
The global atrial fibrillation market is expanding along with the increase in the ageing population. In addition, high blood pressure, obesity, and diabetes result in the increase in occurrence of atrial fibrillation in the geriatric population. According to the Centers for Disease Control and Prevention (CDC) estimates of the prevalence of AFib in the U.S. ranges from about 2.7 million to 6.1 million. That number is estimated to rise to 12.1 million in 2030. Such factors are expected to increase the demand for atrial fibrillation devices during the forecast period. Furthermore, technical advancements in surgical devices for atrial fibrillation propel the atrial fibrillation market forward. However, problems such as expensive atrial fibrillation treatment costs and costly medical devices are expected to hamper the market expansion.
Moreover, technological advancements force key players to introduce atrial fibrillation monitoring and devices in the medical and pharmaceutical sectors. For instance, in February 2020, Janssen Pharmaceutical Companies of Johnson & Johnson collaborated with Apple Inc. and introduced Heartline Monitor. It improves health outcomes, such as lowering the risk of stroke, by detecting atrial fibrillation (AFib) earlier.
The market is segmented on the basis of type, technology, end user and geography. On the basis of type, it is divided into surgical and non-surgical. On the basis of technology, it is divided into radiofrequency, laser, cryotherapy, and others. On the basis of end user, the market is segmented into hospitals, specialty clinics, and others. Region-wise, the market analysis is conducted across North America (the U.S., Canada, and Mexico), Europe (the UK, France, Germany, Italy, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).
The key players operating in the global atrial fibrillation market are Abbott Laboratories, Johnson & Johnson, MicroPort Scientific Corporation, Boston Scientific Corporation, Medtronic plc, Biotronik SE & Co. KG, Philips N.V., Siemens AG, AtriCure Inc., and CardioFocus, Inc.
Key Benefits For Stakeholders
The report provides an extensive analysis of the current and emerging atrial fibrillation market trends and dynamics.
In-depth atrial fibrillation market analysis is conducted by constructing market estimations for key market segments between 2021 and 2030.
Extensive analysis of the atrial fibrillation market is conducted by following key product positioning and monitoring of top competitors within the market framework.
A comprehensive analysis of all the regions is provided to determine the prevailing opportunities.
The global atrial fibrillation market forecast analysis from 2021 to 2030 is included in the report.
The key players within atrial fibrillation market are profiled in this report and their strategies are analyzed thoroughly, which help understand the competitive outlook of the atrial fibrillation industry.
Key Market Segments
By BY TYPE
Surgical
Non-Surgical
By BY TECHNOLOGY
Radiofrequency
Laser
Cryotherapy
Others
By BY END USER
Hospitals
Specialty Clinics
Others
By BY REGION
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
LAMEA
Latin America
Middle East
Africa
Key Market Players
Johnson & Johnson
MicroPort Scientific Corporation
Boston Scientific Corporation
st. jude medical
Medtronic plc
Abbott Laboratories
Biotronik SE & Co. KG
Koninklijke Philips N.V.
Siemens AG
AtriCure Inc
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: ATRIAL FIBRILLATION MARKET, BY TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Surgical
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Non-Surgical
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- CHAPTER 5: ATRIAL FIBRILLATION MARKET, BY TECHNOLOGY
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Radiofrequency
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Laser
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Cryotherapy
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Others
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
- CHAPTER 6: ATRIAL FIBRILLATION MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Hospitals
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Specialty Clinics
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- CHAPTER 7: ATRIAL FIBRILLATION MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Type
- 7.2.3 North America Market size and forecast, by Technology
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Type
- 7.2.5.1.2 Market size and forecast, by Technology
- 7.2.5.1.3 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Type
- 7.2.5.2.2 Market size and forecast, by Technology
- 7.2.5.2.3 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Type
- 7.2.5.3.2 Market size and forecast, by Technology
- 7.2.5.3.3 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Type
- 7.3.3 Europe Market size and forecast, by Technology
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Type
- 7.3.5.1.2 Market size and forecast, by Technology
- 7.3.5.1.3 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Type
- 7.3.5.2.2 Market size and forecast, by Technology
- 7.3.5.2.3 Market size and forecast, by End User
- 7.3.5.3 U.K.
- 7.3.5.3.1 Market size and forecast, by Type
- 7.3.5.3.2 Market size and forecast, by Technology
- 7.3.5.3.3 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Type
- 7.3.5.4.2 Market size and forecast, by Technology
- 7.3.5.4.3 Market size and forecast, by End User
- 7.3.5.5 Rest of Europe
- 7.3.5.5.1 Market size and forecast, by Type
- 7.3.5.5.2 Market size and forecast, by Technology
- 7.3.5.5.3 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Technology
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 China
- 7.4.5.1.1 Market size and forecast, by Type
- 7.4.5.1.2 Market size and forecast, by Technology
- 7.4.5.1.3 Market size and forecast, by End User
- 7.4.5.2 India
- 7.4.5.2.1 Market size and forecast, by Type
- 7.4.5.2.2 Market size and forecast, by Technology
- 7.4.5.2.3 Market size and forecast, by End User
- 7.4.5.3 Japan
- 7.4.5.3.1 Market size and forecast, by Type
- 7.4.5.3.2 Market size and forecast, by Technology
- 7.4.5.3.3 Market size and forecast, by End User
- 7.4.5.4 South Korea
- 7.4.5.4.1 Market size and forecast, by Type
- 7.4.5.4.2 Market size and forecast, by Technology
- 7.4.5.4.3 Market size and forecast, by End User
- 7.4.5.5 Rest of Asia-Pacific
- 7.4.5.5.1 Market size and forecast, by Type
- 7.4.5.5.2 Market size and forecast, by Technology
- 7.4.5.5.3 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Type
- 7.5.3 LAMEA Market size and forecast, by Technology
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Latin America
- 7.5.5.1.1 Market size and forecast, by Type
- 7.5.5.1.2 Market size and forecast, by Technology
- 7.5.5.1.3 Market size and forecast, by End User
- 7.5.5.2 Middle East
- 7.5.5.2.1 Market size and forecast, by Type
- 7.5.5.2.2 Market size and forecast, by Technology
- 7.5.5.2.3 Market size and forecast, by End User
- 7.5.5.3 Africa
- 7.5.5.3.1 Market size and forecast, by Type
- 7.5.5.3.2 Market size and forecast, by Technology
- 7.5.5.3.3 Market size and forecast, by End User
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 Johnson & Johnson
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 MicroPort Scientific Corporation
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 Boston Scientific Corporation
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 st. jude medical
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Medtronic plc
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Abbott Laboratories
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Biotronik SE & Co. KG
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Koninklijke Philips N.V.
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Siemens AG
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 AtriCure Inc
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL ATRIAL FIBRILLATION MARKET, BY TYPE, 2020-2030,($MILLION)
- TABLE 2. ATRIAL FIBRILLATION MARKET REVENUE, FOR SURGICAL, BY REGION , 2020-2030,($MILLION)
- TABLE 3. ATRIAL FIBRILLATION MARKET SURGICAL BY COUNTRY, 2020-2030,($MILLION)
- TABLE 4. ATRIAL FIBRILLATION MARKET REVENUE, FOR NON-SURGICAL, BY REGION , 2020-2030,($MILLION)
- TABLE 5. ATRIAL FIBRILLATION MARKET NON-SURGICAL BY COUNTRY, 2020-2030,($MILLION)
- TABLE 6. GLOBAL ATRIAL FIBRILLATION MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
- TABLE 7. ATRIAL FIBRILLATION MARKET REVENUE, FOR RADIOFREQUENCY, BY REGION , 2020-2030,($MILLION)
- TABLE 8. ATRIAL FIBRILLATION MARKET RADIOFREQUENCY BY COUNTRY, 2020-2030,($MILLION)
- TABLE 9. ATRIAL FIBRILLATION MARKET REVENUE, FOR LASER, BY REGION , 2020-2030,($MILLION)
- TABLE 10. ATRIAL FIBRILLATION MARKET LASER BY COUNTRY, 2020-2030,($MILLION)
- TABLE 11. ATRIAL FIBRILLATION MARKET REVENUE, FOR CRYOTHERAPY, BY REGION , 2020-2030,($MILLION)
- TABLE 12. ATRIAL FIBRILLATION MARKET CRYOTHERAPY BY COUNTRY, 2020-2030,($MILLION)
- TABLE 13. ATRIAL FIBRILLATION MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
- TABLE 14. ATRIAL FIBRILLATION MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 15. GLOBAL ATRIAL FIBRILLATION MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 16. ATRIAL FIBRILLATION MARKET REVENUE, FOR HOSPITALS, BY REGION , 2020-2030,($MILLION)
- TABLE 17. ATRIAL FIBRILLATION MARKET HOSPITALS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 18. ATRIAL FIBRILLATION MARKET REVENUE, FOR SPECIALTY CLINICS, BY REGION , 2020-2030,($MILLION)
- TABLE 19. ATRIAL FIBRILLATION MARKET SPECIALTY CLINICS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 20. ATRIAL FIBRILLATION MARKET REVENUE, FOR OTHERS, BY REGION , 2020-2030,($MILLION)
- TABLE 21. ATRIAL FIBRILLATION MARKET OTHERS BY COUNTRY, 2020-2030,($MILLION)
- TABLE 22. ATRIAL FIBRILLATION MARKET, BY REGION, 2020-2030,($MILLION)
- TABLE 23. NORTH AMERICA ATRIAL FIBRILLATION MARKET, BY TYPE, 2020-2030,($MILLION)
- TABLE 24. NORTH AMERICA ATRIAL FIBRILLATION MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
- TABLE 25. NORTH AMERICA ATRIAL FIBRILLATION MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 26. NORTH AMERICA ATRIAL FIBRILLATION MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 27. U.S. ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 28. U.S. ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 29. U.S. ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
- TABLE 30. CANADA ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 31. CANADA ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 32. CANADA ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
- TABLE 33. MEXICO ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 34. MEXICO ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 35. MEXICO ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
- TABLE 36. EUROPE ATRIAL FIBRILLATION MARKET, BY TYPE, 2020-2030,($MILLION)
- TABLE 37. EUROPE ATRIAL FIBRILLATION MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
- TABLE 38. EUROPE ATRIAL FIBRILLATION MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 39. EUROPE ATRIAL FIBRILLATION MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 40. GERMANY ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 41. GERMANY ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 42. GERMANY ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
- TABLE 43. FRANCE ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 44. FRANCE ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 45. FRANCE ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
- TABLE 46. U.K. ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 47. U.K. ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 48. U.K. ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
- TABLE 49. ITALY ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 50. ITALY ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 51. ITALY ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
- TABLE 52. REST OF EUROPE ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 53. REST OF EUROPE ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 54. REST OF EUROPE ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
- TABLE 55. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET, BY TYPE, 2020-2030,($MILLION)
- TABLE 56. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
- TABLE 57. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 58. ASIA-PACIFIC ATRIAL FIBRILLATION MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 59. CHINA ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 60. CHINA ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 61. CHINA ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
- TABLE 62. INDIA ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 63. INDIA ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 64. INDIA ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
- TABLE 65. JAPAN ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 66. JAPAN ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 67. JAPAN ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
- TABLE 68. SOUTH KOREA ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 69. SOUTH KOREA ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 70. SOUTH KOREA ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
- TABLE 71. REST OF ASIA-PACIFIC ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 72. REST OF ASIA-PACIFIC ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 73. REST OF ASIA-PACIFIC ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
- TABLE 74. LAMEA ATRIAL FIBRILLATION MARKET, BY TYPE, 2020-2030,($MILLION)
- TABLE 75. LAMEA ATRIAL FIBRILLATION MARKET, BY TECHNOLOGY, 2020-2030,($MILLION)
- TABLE 76. LAMEA ATRIAL FIBRILLATION MARKET, BY END USER, 2020-2030,($MILLION)
- TABLE 77. LAMEA ATRIAL FIBRILLATION MARKET, BY COUNTRY, 2020-2030,($MILLION)
- TABLE 78. LATIN AMERICA ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 79. LATIN AMERICA ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 80. LATIN AMERICA ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
- TABLE 81. MIDDLE EAST ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 82. MIDDLE EAST ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 83. MIDDLE EAST ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
- TABLE 84. AFRICA ATRIAL FIBRILLATION MARKET BY TYPE 2020-2030,($MILLION)
- TABLE 85. AFRICA ATRIAL FIBRILLATION MARKET BY TECHNOLOGY 2020-2030,($MILLION)
- TABLE 86. AFRICA ATRIAL FIBRILLATION MARKET BY END USER 2020-2030,($MILLION)
- TABLE 87.JOHNSON & JOHNSON: COMPANY SNAPSHOT
- TABLE 88.JOHNSON & JOHNSON: OPERATING SEGMENTS
- TABLE 89.JOHNSON & JOHNSON: PRODUCT PORTFOLIO
- TABLE 90.JOHNSON & JOHNSON: NET SALES,
- TABLE 91.JOHNSON & JOHNSON: KEY STRATERGIES
- TABLE 92.MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
- TABLE 93.MICROPORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS
- TABLE 94.MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
- TABLE 95.MICROPORT SCIENTIFIC CORPORATION: NET SALES,
- TABLE 96.MICROPORT SCIENTIFIC CORPORATION: KEY STRATERGIES
- TABLE 97.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
- TABLE 98.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
- TABLE 99.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
- TABLE 100.BOSTON SCIENTIFIC CORPORATION: NET SALES,
- TABLE 101.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
- TABLE 102.ST. JUDE MEDICAL: COMPANY SNAPSHOT
- TABLE 103.ST. JUDE MEDICAL: OPERATING SEGMENTS
- TABLE 104.ST. JUDE MEDICAL: PRODUCT PORTFOLIO
- TABLE 105.ST. JUDE MEDICAL: NET SALES,
- TABLE 106.ST. JUDE MEDICAL: KEY STRATERGIES
- TABLE 107.MEDTRONIC PLC: COMPANY SNAPSHOT
- TABLE 108.MEDTRONIC PLC: OPERATING SEGMENTS
- TABLE 109.MEDTRONIC PLC: PRODUCT PORTFOLIO
- TABLE 110.MEDTRONIC PLC: NET SALES,
- TABLE 111.MEDTRONIC PLC: KEY STRATERGIES
- TABLE 112.ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 113.ABBOTT LABORATORIES: OPERATING SEGMENTS
- TABLE 114.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 115.ABBOTT LABORATORIES: NET SALES,
- TABLE 116.ABBOTT LABORATORIES: KEY STRATERGIES
- TABLE 117.BIOTRONIK SE & CO. KG: COMPANY SNAPSHOT
- TABLE 118.BIOTRONIK SE & CO. KG: OPERATING SEGMENTS
- TABLE 119.BIOTRONIK SE & CO. KG: PRODUCT PORTFOLIO
- TABLE 120.BIOTRONIK SE & CO. KG: NET SALES,
- TABLE 121.BIOTRONIK SE & CO. KG: KEY STRATERGIES
- TABLE 122.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
- TABLE 123.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
- TABLE 124.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
- TABLE 125.KONINKLIJKE PHILIPS N.V.: NET SALES,
- TABLE 126.KONINKLIJKE PHILIPS N.V.: KEY STRATERGIES
- TABLE 127.SIEMENS AG: COMPANY SNAPSHOT
- TABLE 128.SIEMENS AG: OPERATING SEGMENTS
- TABLE 129.SIEMENS AG: PRODUCT PORTFOLIO
- TABLE 130.SIEMENS AG: NET SALES,
- TABLE 131.SIEMENS AG: KEY STRATERGIES
- TABLE 132.ATRICURE INC: COMPANY SNAPSHOT
- TABLE 133.ATRICURE INC: OPERATING SEGMENTS
- TABLE 134.ATRICURE INC: PRODUCT PORTFOLIO
- TABLE 135.ATRICURE INC: NET SALES,
- TABLE 136.ATRICURE INC: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.ATRIAL FIBRILLATION MARKET SEGMENTATION
- FIGURE 2.ATRIAL FIBRILLATION MARKET,2020-2030
- FIGURE 3.ATRIAL FIBRILLATION MARKET,2020-2030
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.ATRIAL FIBRILLATION MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 11.ATRIAL FIBRILLATION MARKET,BY TYPE,2020(%)
- FIGURE 12.COMPARATIVE SHARE ANALYSIS OF SURGICAL ATRIAL FIBRILLATION MARKET,2020-2030(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF NON-SURGICAL ATRIAL FIBRILLATION MARKET,2020-2030(%)
- FIGURE 14.ATRIAL FIBRILLATION MARKET,BY TECHNOLOGY,2020(%)
- FIGURE 15.COMPARATIVE SHARE ANALYSIS OF RADIOFREQUENCY ATRIAL FIBRILLATION MARKET,2020-2030(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF LASER ATRIAL FIBRILLATION MARKET,2020-2030(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF CRYOTHERAPY ATRIAL FIBRILLATION MARKET,2020-2030(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF OTHERS ATRIAL FIBRILLATION MARKET,2020-2030(%)
- FIGURE 19.ATRIAL FIBRILLATION MARKET,BY END USER,2020(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HOSPITALS ATRIAL FIBRILLATION MARKET,2020-2030(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF SPECIALTY CLINICS ATRIAL FIBRILLATION MARKET,2020-2030(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF OTHERS ATRIAL FIBRILLATION MARKET,2020-2030(%)
- FIGURE 23.ATRIAL FIBRILLATION MARKET BY REGION,2020
- FIGURE 24.U.S. ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
- FIGURE 25.CANADA ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
- FIGURE 26.MEXICO ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
- FIGURE 27.GERMANY ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
- FIGURE 28.FRANCE ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
- FIGURE 29.U.K. ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
- FIGURE 30.ITALY ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
- FIGURE 31.REST OF EUROPE ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
- FIGURE 32.CHINA ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
- FIGURE 33.INDIA ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
- FIGURE 34.JAPAN ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
- FIGURE 35.SOUTH KOREA ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
- FIGURE 36.REST OF ASIA-PACIFIC ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
- FIGURE 37.LATIN AMERICA ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
- FIGURE 38.MIDDLE EAST ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
- FIGURE 39.AFRICA ATRIAL FIBRILLATION MARKET,2020-2030($MILLION)
- FIGURE 40. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 43.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 44.COMPETITIVE DASHBOARD
- FIGURE 45.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 46.JOHNSON & JOHNSON.: NET SALES ,($MILLION)
- FIGURE 47.MICROPORT SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
- FIGURE 48.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
- FIGURE 49.ST. JUDE MEDICAL.: NET SALES ,($MILLION)
- FIGURE 50.MEDTRONIC PLC.: NET SALES ,($MILLION)
- FIGURE 51.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
- FIGURE 52.BIOTRONIK SE & CO. KG.: NET SALES ,($MILLION)
- FIGURE 53.KONINKLIJKE PHILIPS N.V..: NET SALES ,($MILLION)
- FIGURE 54.SIEMENS AG.: NET SALES ,($MILLION)
- FIGURE 55.ATRICURE INC.: NET SALES ,($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook